Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for claudin- 1
Most Correlated Studies
- Ovarian cancer cell lines OVCA420 and OVCAR-2 with and without silencing of claudin-7
- Kidney gene expression in claudin-16 homozygous wildtype, homozygous mutant and heterozygous mice
- Mouse chondrocytes treated with inhibitors of PI3K, histone deacetylase, and Mek/ERK pathway
- Oncogenic PI3K mutations in cancer cells following growth factor deprivation
- Breast adenocarcinoma MCF7 cells treated with delta-2-troglitazone
Most Relevant Literature
- Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression.
- Micro RNA-175 Targets Claudin-1 to Inhibit Madin-Darby Canine Kidney Cell Adhesion.
- PC (16:0/14:0) ameliorates hyperoxia-induced bronchopulmonary dysplasia by upregulating claudin-1 an…
- Development of tight junction-strengthening compounds using a high-throughput screening system to ev…
- Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
Most Relevant Clinical Trials
- Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
- TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
- Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
- Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901
